Literature DB >> 10708738

Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats.

A Y Bespalov1, O A Dravolina, E E Zvartau, P M Beardsley, R L Balster.   

Abstract

NMDA receptor antagonists have been reported to affect learned behaviors conditioned with abused drugs, with the outcome dependent, in part, on the class of NMDA receptor antagonist used. The present study tested the ability of various site-selective NMDA receptor antagonists to modify cocaine-conditioned motor activity. Two procedures were used for independently assessing drug effects on spontaneous activity and expression of cocaine-conditioned behavior. In the conditioning experiments, rats were administered i.p. injections of cocaine (30 mg/kg) or saline paired with distinctive environments. Spontaneous horizontal activity was dose-dependently enhanced by dizocilpine (0.03-0.3 mg/kg) and memantine (1-30 mg/kg), but not by D-CPPene (3-(2-carboxypiperazin-4-yl)-1-propenyl-1-phosphonic acid; SDZ EAA 494; 1-10 mg/kg), ACEA-1021 (5-nitro-6,7-dichloro-1,4-dihydro-2, 3-quinoxalinedione; 3-56 mg/kg), or eliprodil (3-30 mg/kg). Higher doses of memantine, D-CPPene (1-10 mg/kg), eliprodil (3-30 mg/kg), or ACEA-1021 reduced vertical activity. Following five cocaine-environment pairings, rats displayed significant increases in motor activity when exposed to the cocaine-paired environment. The following antagonists were administered prior to the conditioning test: dizocilpine (MK-801; 0.03-0.1 mg/kg), memantine (1-10 mg/kg), D-CPPene (0.3-3 mg/kg), ACEA-1021 (3-10 mg/kg), and eliprodil (1-10 mg/kg). Of these, memantine, ACEA-1021 and, to the lesser degree, eliprodil attenuated expression of cocaine-conditioned motor activity at doses that did not significantly affect spontaneous motor activity. These results show that cocaine-conditioned behaviors can be selectively modulated by some, but not all, NMDA receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708738     DOI: 10.1016/s0014-2999(99)00927-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period.

Authors:  Adam Bisaga; Efrat Aharonovich; Wendy Y Cheng; Frances R Levin; John J Mariani; Wilfrid N Raby; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

2.  Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats.

Authors:  Olga A Dravolina; Wojciech Danysz; Anton Y Bespalov
Journal:  Psychopharmacology (Berl)       Date:  2006-06-20       Impact factor: 4.530

Review 3.  Do specific NMDA receptor subunits act as gateways for addictive behaviors?

Authors:  F W Hopf
Journal:  Genes Brain Behav       Date:  2016-11-18       Impact factor: 3.449

4.  Effects of memantine, haloperidol, and cocaine on primary and conditioned reinforcement associated with cocaine in rhesus monkeys.

Authors:  Jennifer L Newman; Patrick M Beardsley
Journal:  Psychopharmacology (Berl)       Date:  2006-01-20       Impact factor: 4.530

5.  Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice.

Authors:  Michael J Glass; Deborah M Hegarty; Martin Oselkin; Laarni Quimson; Samantha M South; Qinghao Xu; Virginia M Pickel; Charles E Inturrisi
Journal:  Exp Neurol       Date:  2008-05-20       Impact factor: 5.330

Review 6.  Cocaine-induced Changes in the Expression of NMDA Receptor Subunits.

Authors:  Irena Smaga; Marek Sanak; Małgorzata Filip
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

7.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.